Patent US5535261A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3931402A Expired / Lapsed US ⏱️ 0.0 years remaining

Preparations containing hexoses

Assignee: Prodotti Antibiotici SpA
•
Filing: 1973-07-06
•
Granted: 1976-01-06
•
Expires: 1993-07-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There are described preparations containing glucides and non-toxic, physiologically compatible salts of phosphorylated glucides which can be administered orally or parenterally.

Inventors

  • 👤 Giuseppe Ghielmetti
  • 👤 Rodolfo Ferrari

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 15:17
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 47 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose with a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate, and 6-phosphogluconate, said salt constituting 0.1-50% by weight of the mixture.
Claim 2
Dependent Claim 47 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose with a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate, and 6-phosphogluconate, said salt constituting 0.1-50% by weight of the mixture.
Claim 3
Dependent Claim 36 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of fructose with an alkali metal salt of fructose-1,6-diphosphate, said salt constituting 0.1-50% by weight of the mixture.
Claim 4
Dependent Claim 36 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of fructose with an alkali metal salt of fructose-1,6-diphosphate, said salt constituting 0.1-50% by weight of the mixture.
Claim 5
Dependent Claim 48 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose, fructose and a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate and 6-phosphogluconate, said salt constituting 0.1-50% by weight of the mixture.
Claim 6
Dependent Claim 48 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose, fructose and a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate and 6-phosphogluconate, said salt constituting 0.1-50% by weight of the mixture.
Claim 7
Dependent Claim 54 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose, fructose, a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate and 6-phosphogluconate and an alkali metal salt of fructose-1,6-phosphate, said salts constituting 0.1-50% by weight of the mixture.
Claim 8
Dependent Claim 54 words
A composition useful for administering an immediate source of energy to a patient consisting essentially of a mixture of glucose, fructose, a salt selected from the group consisting of an alkali metal salt of glucose-1-phosphate, glucose-6-phosphate and 6-phosphogluconate and an alkali metal salt of fructose-1,6-phosphate, said salts constituting 0.1-50% by weight of the mixture.
Claim 9
Dependent Claim 22 words
A sterile aqueous solution of the composition of claim 1 containing a therapeutically effective amount thereof up to about 6% by weight.
Claim 10
Dependent Claim 22 words
A sterile aqueous solution of the composition of claim 2 containing a therapeutically effective amount thereof up to about 6% by weight.
Claim 11
Dependent Claim 22 words
A sterile aqueous solution of the composition of claim 3 containing a therapeutically effective amount thereof up to about 6% by weight.
Claim 12
Dependent Claim 22 words
A sterile aqueous solution of the composition of claim 4, containing a therapeutically effective amount thereof up to about 6% by weight.
Claim 13
Dependent Claim 17 words
A composition according to claim 1 wherein the alkali metal salt is the sodium or potassium salt.
Claim 14
Dependent Claim 17 words
A composition according to claim 2 wherein the alkali metal salt is the sodium of potassium salt.
Claim 15
Dependent Claim 17 words
A composition according to claim 3 wherein the alkali metal salt is the sodium or potassium salt.
Claim 16
Dependent Claim 17 words
A composition according to claim 4 wherein the alkali metal salt is the sodium or potassium salt.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-01-05 1979-07-07 1980-01-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-01-05 1983-07-07 1984-01-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-01-05 1987-07-07 1988-01-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag